Goldman Sachs’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-12,800
Closed -$1.46M – 5640
2018
Q3
$1.46M Buy
+12,800
New +$1.45M ﹤0.01% 3803
2017
Q2
– Sell
-50,000
Closed -$3.47M – 6962
2017
Q1
$3.47M Hold
50,000
– – ﹤0.01% 3240
2016
Q4
$3.37M Sell
50,000
-11,600
-19% -$787K ﹤0.01% 3400
2016
Q3
$4.5M Hold
61,600
– – ﹤0.01% 3129
2016
Q2
$4.24M Hold
61,600
– – ﹤0.01% 2995
2016
Q1
$4.38M Hold
61,600
– – ﹤0.01% 2824
2015
Q4
$4.64M Buy
+61,600
New +$4.45M ﹤0.01% 2895
2015
Q2
– Sell
-55,000
Closed -$3.87M – 7427
2015
Q1
$3.87M Sell
55,000
-55,000
-50% -$3.63M ﹤0.01% 3138
2014
Q4
$7.13M Buy
+110,000
New +$6.79M ﹤0.01% 2648

Other funds holding STE

Goldman Sachs's STE Position: Q2 2026 in Review

Goldman Sachs increased its Steris (STE) stake by 257% in Q2 2026, buying an estimated $210M and bringing the position to 1,363,145 shares worth $287M. The position accounts for 0.02% of the portfolio, ranked #613.

Goldman Sachs first reported a position in STE in Q2 2013 and has held it in 53 quarters since. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Goldman Sachs held 1,363,145 shares of Steris worth $287M as of Q2 2026.
  • Goldman Sachs bought 981,568 Steris shares in Q2 2026, an estimated $210M.
  • Steris made up 0.02% of Goldman Sachs's portfolio in Q2 2026, its #613 holding.
  • Goldman Sachs first reported a position in Steris in Q2 2013 and has held it in 53 quarters since.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.